bioRN Life Science Cluster

BioRN is the science and industry innovation cluster in the Rhine-Neckar region around Heidelberg, one of Germany’s strongest biotech and life science hubs. It is a non-profit network fostering health innovations and serving its members by creating a rich translational ecosystem as well as promoting, representing and connecting the regional innovation stakeholders.

create innovation …
… foster translation!

The bioRN Life Science Cluster establishes initiatives to bridge the regional innovation stakeholders and to nurture and extend connections between members. It also fosters connections to other regions of innovation worldwide and stands for the promotion and visibility of the life science region at the national and international level.

Follow us on

We act as a neutral player, supporting cross-organizational programs and initiatives that advance the life science region as a whole. At the interface between academia and industry, bioRN provides translation support, especially by leveraging the unique combination of global pharma and leading academic institutions in the region.

Our Core Values

bioRN Team

Dr. Julia Schaft

Dr. Julia Schaft

Managing Director

Michelle Sommer

Michelle Sommer

Communication Assistant

Dr. Arantxa Encinas-López

Dr. Arantxa Encinas-López

Startup Project Manager

Daniela Weber

Daniela Weber

Project Manager
Regional Ecosystem

Dr. Friedemann Loos

Dr. Friedemann Loos

Innovation Manager

Dr. Nicole Hecht

Dr. Nicole Hecht

Communication and Events

Sibylle Geilenberg

Sibylle Geilenberg

Office Manager

Stephanie Füller

Stephanie Füller

Public Relations Manager

Projects

Explore how our team manage currently these projects and achieved already great success

4 /
EIT Health Catapult

EIT Health Catapult: fast-tracking Europe’s best start-ups! Introducing a unique competition and training programme that showcases life sciences and health tech start-ups to leading experts and investors across Europe. The programme awards the best business concepts.

PRECISEU

BioRN was instrumental in the conception and successful application of PRECISEU, a European flagship project funded with tens of millions of euros, which aims to enable personalized medicine through the use of health data and the development of advanced therapy medicinal products (ATMPs). Thanks to the strong anchoring of personalized medicine in the region and the high density of academic and industrial excellence in the healthcare sector, bioRN will play a key role as Innovation Lead within the consortium and thus profile the region internationally as a leading location for the healthcare industry.

Think Tank Data Exchange

This Think Tank aims to raise awareness, foster collaborations, and develop clear guidelines for the efficient exchange of clinical data and research results between academia and industry, enhancing both patient care and research outcomes in the biotech cluster. Interested? Please contact Friedemann Loos fl@biorn.org

Think Tank HR in Life Science

This Think Tank will bring together HR managers to exchange ideas, share experiences, and collaboratively develop creative solutions for overcoming talent shortages, all in an informal breakfast setting. Interested? Please contact Stephanie Füller sf@biorn.org

Think Tank Investment

Together we will find out how to attract more investors for this region

Lighthouse Stories

1 /

Board & Honorary

Dr. Gitte  Neubauer (Chair)

Dr. Gitte Neubauer (Chair)

CEO of Cellzome GmbH – a GSK company, Heidelberg

Prof. Dr. Michael Boutros (Deputy Chair)

Prof. Dr. Michael Boutros (Deputy Chair)

Head of Functional and Structural Genomics Program at the German Cancer Research Center (DKFZ), Heidelberg Dean of Medical Faculty Heidelberg, University Heidelberg

Prof. Dr. Adelheid Cerwenka

Prof. Dr. Adelheid Cerwenka

Professor and Chair of Immunobiochemistry, Vice Dean of Research, Mannheim Institute for Innate Immunoscience (MI3), Heidelberg University, Medical Faculty Mannheim

Dr. Angelika Vlachou

Dr. Angelika Vlachou

Partner, High-Tech Gründerfonds Management GmbH (HTGF), Bonn

Marc Massoth

Marc Massoth

Head of Office for Business Development and Science, City of Heidelberg

Dr. Claus Kremoser

Dr. Claus Kremoser

Chief Executive Officer & Executive Board, WMT AG, Heidelberg

Dr. Volker Stadler

Dr. Volker Stadler

CEO of PEPperPRINT GmbH, Heidelberg

The strategic board is an advisory body, endoursed with the task of advising the executive board particularly on strategic issues or reviewing executive board decisions.

Dr. Chistian Tidona (Chair)

Managing Director BioMed X GmbH, Heidelberg

Dr. Jürgen Bauer

Deputy Managing Director EMBLEM Technology Transfer GmbH, Heidelberg

Katja Betts

CEO PROGEN Biotechnik GmbH Heidelberg

Dr. Ulrich Betz

Senior Vice President Innovation, Merck KGaA, Darmstadt

Dr. Siegfried Bialojan

Biotech Expert

Dr. Sophia Deil

CEO ScienceValue Heidelberg GmbH

Katharina Fox

Medical Technology Cluster Management, Mannheim

Dr. Jürgen Gamer

TET Systems GmbH

Dr. Jan Gradel

City of Heidelberg, Heidelberg

Martin Haag

Site Manager, Roche Diagnostics GmbH, Mannheim

Dr. Thomas Hanke

Evotec International GmbH, EVP, Head of Academic Partnerships, Hamburg

Prof. Dr. Carsten Hopf

Head of Institute for Instrumental Analytics and Bioanalytics Mannheim University of Applied Sciences

Andreas Kempff

Managing Director, Department of Industry, Innovation and Enterprise Promotion, Chamber of Industry and Commerce (IHK) Rhine-Neckar, Heidelberg

Dr. Bernd Nosse

Global Head BD&L Technologies and Research Beyond Boarders, Boehringer Ingelheim International GmbH, Ingelheim

Prof. Dr. Katja Patzel-Mattern

Vice President for Innovation and Transfer, Professor of Economic and Social History, Heidelberg University, Heidelberg

Dr. Martin Raditsch

CEO INNOVECTIS GmbH, Frankfurt am Main, General Partner CARMA FUND Management GmbH & CEO Innovectis GmbH

Dr. Kirstin Schilling

CEO INNOVECTIS GmbH, Frankfurt am Main

Dr. Oliver Schlüter

CEO/CFO Novaliq GmbH, Heidelberg

Dr. Joachim Vogt

Director Search & Evaluation Western Europe at AbbVie

Dr. Rainer Wessel

Director Innovation Management, German Cancer Research Center (DKFZ), Heidelberg

Prof. Dr. Heike Andrea Wieland

Director External Ecosystem R&D, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main

The Scientific Advisory Board is an advisory body entrusted with the task of advising the executive board particularly in the selection and evaluation of project ideas and projects.

Prof. Dr. Mathias Hafner (Chair)

Vice President for Research and Technology Transfer at Mannheim University of Applied Sciences

Prof. Dr. Bernd Bukau

Director of Zentrum für Molekulare Biologie Heidelberg (ZMBH)

Dr. Christoph Antz

CEO, VERAXA Biotech GmbH, Heidelberg

Prof. Dr. Magnus von Knebel Doeberitz

Medical Director, Department Head at University Hospital Heidelberg

Ralf Angermund M.D. Ph.D

Early Innovation Partnering Director Deutschland, Janssen-Cilag GmbH (Johnson & Johnson)

Prof. Dr. Sonja Loges

Director, W3 Professor, Department of Personalized Oncology, Director, Division of Personalized Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg

Prof. Dr. Patrick Most

Head of the Molecular and Translational Cardiology Section, Heidelberg, CEO and Co-Founder AaviGen GmbH, Heidelberg

Prof. Dr. Nina Papavasiliou

Head of Division of Immune Diversity, German Cancer Research Center (DKFZ), Heidelberg

Prof. Dr. Michael Platten

Chairman Department of Neurology, Medical Faculty Mannheim, Heidelberg University; Head of Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg; Founder and Managing Director Tcelltech, Mannheim

Dr. Birgit Zech

CEO Anavo Therapeutics B.V., Leiden

Dr. Daniel Forler

Senior Director BD&L, New Platforms /OPH/HEM, Bayer AG, Berlin

Dr. Thomas Höger

CEO and co-founder, Apogenix GmbH, Heidelberg

Dr. Friedrich Rippmann

ex-Merck KGaA, Darmstadt

Prof. Dr. Andreas Trumpp

Managing Director of HI-STEM, Professor and Head of the Division of Stem Cell and Cancer at the DKFZ Heidelberg

Interested but don’t know where to start?

Get in touch

Stay updated with bioRN’s newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp’s privacy practices.

Intuit Mailchimp